Phio Pharmaceuticals Corp. (PHIO) Leads Way for Corrections After Gaining Over 150% on Antitumor Efficacy Data
On Friday, hot penny stock Phio Pharmaceuticals Corp. (PHIO) fell under corrections after its spiked up in regular trading. The company announced new data on its PH-894 with antitumor efficacy which will be presented at the AACR Annual Meeting, on the day. Consequently, the stock shot up by a huge 159.18% in regular trading at […]